JAPAN TOB Research and Development Expenses 2016-2026 | JAPAY

JAPAN TOB annual/quarterly research and development expenses history and growth rate from 2016 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • JAPAN TOB research and development expenses for the quarter ending March 31, 2026 were $0M, a 0% increase year-over-year.
  • JAPAN TOB research and development expenses for the twelve months ending March 31, 2026 were $0M, a 0% increase year-over-year.
  • JAPAN TOB annual research and development expenses for 2025 were $0B, a 0% decline from 2024.
  • JAPAN TOB annual research and development expenses for 2024 were $0B, a 0% decline from 2023.
  • JAPAN TOB annual research and development expenses for 2023 were $0B, a 0% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
JAPAN TOB Annual Research and Development Expenses
(Millions of US $)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
JAPAN TOB Quarterly Research and Development Expenses
(Millions of US $)
2026-03-31
2025-09-30
2025-03-31
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
2019-03-31
2018-03-31
2017-03-31
2016-03-31
2015-12-31
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $66.869B $23.195B
Japan Tobacco Inc. manufactures, markets and sells cigarettes and other tobacco products. It also engaged in pharmaceutical and food businesses. Japan Tobacco Inc. is based in MINATO-KU TKY.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $250.066B 21.28
British American Tobacco (BTI) United Kingdom $120.087B 0.00
Altria (MO) United States $112.613B 12.43
Imperial Tobacco Group (IMBBY) United Kingdom $32.506B 0.00
Turning Point Brands (TPB) United States $1.616B 26.70
Universal (UVV) United States $1.332B 13.73
Ispire Technology (ISPR) United States $0.100B 0.00
Charlie's Holdings (CHUC) United States $0.066B 24.20
22nd Century (XXII) United States $0.001B 0.00